Financial Performance - The company's revenue for Q1 2025 reached ¥176,688,793.53, representing a 31.32% increase compared to ¥134,549,472.48 in the same period last year[4] - Net profit attributable to shareholders was ¥11,175,282.28, up 39.66% from ¥8,001,565.58 year-on-year[4] - The net profit excluding non-recurring gains and losses increased by 60.10% to ¥10,117,891.83 from ¥6,319,799.07 in the previous year[4] - Basic and diluted earnings per share rose to ¥0.10, a 42.86% increase from ¥0.07 in the same period last year[4] - Total operating revenue for the current period reached ¥176,688,793.53, an increase of 31.3% compared to ¥134,549,472.48 in the previous period[20] - Net profit for the current period was ¥11,641,356.18, representing a 32.3% increase from ¥8,767,971.22 in the previous period[22] - Earnings per share (EPS) for the current period was ¥0.10, compared to ¥0.07 in the previous period[22] Assets and Liabilities - The total assets at the end of Q1 2025 were ¥1,713,352,169.16, reflecting a 1.52% increase from ¥1,687,737,410.13 at the end of the previous year[4] - Total current assets decreased slightly to ¥721,990,703.10 from ¥731,163,266.12[17] - Total liabilities increased to ¥305,455,562.26 from ¥291,947,347.90, indicating a rise in short-term borrowings[17] - The company's total assets stand at ¥1,713,352,169.16, up from ¥1,687,737,410.13[17] - Total liabilities amounted to ¥330,096,959.00, compared to ¥316,977,020.15 in the previous period[18] - Total equity attributable to shareholders of the parent company was ¥1,351,900,960.08, an increase from ¥1,339,872,213.80 in the previous period[18] Cash Flow - Cash flow from operating activities decreased by 27.95% to ¥10,091,294.39 from ¥14,005,060.14 year-on-year[4] - Cash inflow from operating activities totaled ¥147,784,344.63, an increase from ¥134,564,635.99 in the previous period[24] - The net cash flow from operating activities was CNY 10,091,294.39, a decrease of 28.5% compared to CNY 14,005,060.14 in the previous period[25] - Cash inflow from investment activities totaled CNY 49,883,135.95, down 65.0% from CNY 142,806,265.19 in the prior period[25] - The net cash flow from investment activities was CNY 3,310,538.94, a significant decrease of 95.8% compared to CNY 78,848,297.85 in the previous period[25] - Cash inflow from financing activities was CNY 1,086,260.45, a decrease of 46.9% from CNY 2,041,576.33 in the prior period[25] - The total cash and cash equivalents at the end of the period amounted to CNY 74,226,747.09, down 71.5% from CNY 260,333,086.05 at the end of the previous period[25] Shareholder Information - Total number of common shareholders at the end of the reporting period is 8,483[13] - The largest shareholder, Liansheng Chemical Group, holds 52.78% of shares, totaling 57,000,000 shares[13] Operational Metrics - The company reported a significant increase in prepayments, which rose by 135.21% to ¥16,653,221.75 due to higher advance payments for raw materials[10] - Investment income surged by 226.57% to ¥198,656.81, attributed to the redemption of financial products exceeding the previous year's amount[11] - The company experienced a 95.80% decline in net cash flow from investing activities, dropping to ¥3,310,538.94 from ¥78,848,297.85 year-on-year[11] - The accounts receivable increased to ¥107,004,672.66 from ¥103,647,203.66, reflecting a growth in sales[16] - Inventory decreased to ¥87,486,312.81 from ¥95,111,078.72, suggesting improved inventory management[16] - The company has a significant investment in construction projects, with ongoing projects valued at ¥584,937,869.19[17] - The company reported a decrease in employee compensation liabilities to ¥5,167,418.00 from ¥13,837,761.71, indicating potential cost-cutting measures[17] - Research and development expenses increased to ¥4,219,150.75, up from ¥3,672,063.05 in the previous period[21] Tax Liabilities - Deferred income tax liabilities rose to ¥103,546.11 from ¥53,450.48 in the previous period[18]
联盛化学(301212) - 2025 Q1 - 季度财报